title: [Treatment of primary cancer of the breast in elderly women. Role of hormone therapy].
abstract: About 40 percent of newly diagnosed breast cancers occur in women older than 65. Hormonotherapy plays an important role as adjuvant treatment of primary cancers in post-menopausal women because of their great hormone-dependence. The drug of choice is tamoxifen which is very well tolerated. Its beneficial effect appears to be related to the duration of administration. It also seems to be particularly promising in the initial treatment (neoadjuvant) of elderly women and potentially beneficial in the breast cancers said to be of good prognosis when the axillary nodes are not involved.
authors: Service d'Oncologie médicale, Groupe hospitalier Pitié-Salpétrière, Paris.
authors: G
authors: G
authors: Auclerc
authors: M
authors: M
authors: Weil
authors: C
authors: C
authors: Borel
authors: D
authors: D
authors: Khayat
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D013629:Tamoxifen
vernacular_title: Traitement du cancer primitif du sein de la femme âgée. Place de l'hormonothérapie.